Abeona Therapeutics (ABEO) Research & Development (2011 - 2026)

Abeona Therapeutics' Research & Development history runs 16 years deep, the most recent figure standing at $9.6 million for Q1 2026.

• On a quarterly basis, Research & Development fell 3.88% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 28.76% decrease from a year earlier, with the FY2025 full-year figure at $26.8 million, down 21.97% from the prior year.
• Research & Development improved to $9.6 million in Q1 2026 per ABEO's latest filing, from $6.7 million in the prior quarter.
• Across five years, Research & Development topped out at $10.5 million in Q1 2022 and bottomed at $4.2 million in Q3 2025.
• The 5-year median for Research & Development is $7.4 million (2023), against an average of $7.7 million.
• Biggest YoY gain for Research & Development was 37.94% in 2025; the steepest drop was 52.85% in 2025.
• Year by year, Research & Development stood at $6.3 million in 2022, then rose by 17.65% to $7.4 million in 2023, then grew by 21.89% to $9.0 million in 2024, then retreated by 25.37% to $6.7 million in 2025, then soared by 42.36% to $9.6 million in 2026.
• Per Business Quant, the three latest ABEO Research & Development figures stand at $9.6 million (Q1 2026), $6.7 million (Q4 2025), and $4.2 million (Q3 2025).